Your browser doesn't support javascript.
loading
Progressive retinal changes in pediatric multiple sclerosis.
Longoni, Giulia; Brown, Robert A; Oyefiade, Ade; Iruthayanathan, Renisha; Wilbur, Colin; Shams, Shahriar; Noguera, Austin; Grover, Stephanie A; O'Mahony, Julia; Chung, Luke; Wan, Michael J; Mah, Jean K; Costello, Fiona; Arnold, Douglas L; Marrie, Ruth Ann; Bar-Or, Amit; Banwell, Brenda; Mabbott, Donald; Reginald, Arun Y; Yeh, E Ann.
Afiliación
  • Longoni G; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Brown RA; McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
  • Oyefiade A; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Iruthayanathan R; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Wilbur C; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, Division of Neurology, University of Toronto, Toronto, ON, Canada.
  • Shams S; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Noguera A; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Grover SA; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • O'Mahony J; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Chung L; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Wan MJ; Department of Ophthalmology and Visual Sciences, The University of Toronto, Toronto, ON, Canada.
  • Mah JK; Departments of Clinical Neurosciences and Surgery, Cumming School of Medicine, University of Calgary, AB, Canada.
  • Costello F; Departments of Clinical Neurosciences and Surgery, Cumming School of Medicine, University of Calgary, AB, Canada.
  • Arnold DL; McConnell Brain Imaging Centre, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada; Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
  • Marrie RA; Departments of Internal Medicine and Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Canada.
  • Bar-Or A; Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Banwell B; Division of Neurology, The Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  • Mabbott D; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada.
  • Reginald AY; Department of Ophthalmology and Visual Sciences, The University of Toronto, Toronto, ON, Canada.
  • Yeh EA; Department of Neurosciences and Mental Health, The Hospital for Sick Children, Toronto, ON, Canada; Department of Pediatrics, Division of Neurology, University of Toronto, Toronto, ON, Canada. Electronic address: ann.yeh@sickkids.ca.
Mult Scler Relat Disord ; 61: 103761, 2022 May.
Article en En | MEDLINE | ID: mdl-35349885
ABSTRACT
Objectives To determine to what extent acute demyelinating episodes versus chronic degenerative phenomena drive retinal neuroaxonal damage in pediatric acquired demyelinating syndromes (ADS). Methods We acquired optical coherence tomography (OCT) data (follow-up range 2 weeks - 5 years, at variable intervals from presentation) in pediatric participants who had multiple sclerosis (MS), monophasic ADS, or were healthy. Multivariable mixed effects models were used to assess the association of the number of demyelinating episodes (either optic neuritis [ON], or non-ON relapses) with changes in retinal nerve fiber layer (RNFL) or ganglion cell layer-inner plexiform layer (GCIPL) thickness. Results 64 OCT sans from 23 MS, and 33 scans from 12 monophasic ADS participants were compared with 68 scans from 62 healthy participants. The first ON episode had the biggest impact on RNFL or GCIPL thickness in monophasic ADS (RNFL -7.9 µm, CI=5.5, p = 0.0056; GCIPL -8.4 µm, CI=4.4, p = 0.0002) and MS (RNFL -16 µm, CI = 3.7, p < 10-6; GCIPL -15 µm, CI = 2.6, p < 10-6). Non-ON relapses were also associated with small but significant retinal thickness reductions in MS (RNFL -2.6 µm/relapse, CI = 1.4, p = 0.0003; GCIPL -2.8 µm/relapse, CI = 0.89, p < 10-6). MS participants showed progressive GCIPL thinning independent of acute demyelinating episodes (-2.7 µm/year, CI = 1.9, p = 0.0058). Conclusions We showed a prominent impact of early ON episodes on OCT measures of neuroaxonal structure in patients with ADS. We also demonstrated negative effects of non-ON relapses, and the presence of chronic retinal neurodegenerative changes, in youth with MS.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Retina / Neuritis Óptica / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades de la Retina / Neuritis Óptica / Esclerosis Múltiple Tipo de estudio: Prognostic_studies Límite: Adolescent / Child / Humans Idioma: En Revista: Mult Scler Relat Disord Año: 2022 Tipo del documento: Article País de afiliación: Canadá